Optimism despite COVID-19 impact on antimicrobial resistance

(Credit: Unsplash)

This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum.

Author: Lars Rebien Sorensen, Chairman of the Board of Directors, Novo Nordisk Foundation


  • Antimicrobial resistance (AMR) is top 10 public health threat according to WHO.
  • Experience gained during global response to COVID-19 could help with AMR prevention.
  • Investment needed to fix the antibiotics market and better protect the world.

Vaccines against the coronavirus are causing optimism across the world. The COVID-19 pandemic will eventually be over, but the lesser-known antimicrobial resistance (AMR) epidemic has only been accelerated by COVID-19. We should use the current momentum from the coordinated worldwide response to defeat the AMR pandemic. Like viruses, resistant bacteria know no borders, and no country can tackle the challenge on its own.

Antimicrobial resistance is a top 10 global public health threat, according to the World Health Organization. Every year, more than 700,000 people die globally from antimicrobial-resistant infections. This corresponds to approximately 2,000 fatalities a day. According to projections from various thinktanks, by 2050 this death rate may reach 10 million a year, unless we manage to solve the problem of antimicrobial resistance. We rely on the availability of effective antibiotics to treat patients throughout the healthcare system, including infections related to COVID-19, leaving nearly every aspect of modern healthcare treatment at risk.

COVID-19 has added another layer of complexity, with antibiotics being overprescribed to COVID-19 patients around the world—as symptoms are similar to those of bacterial pneumonia—even though it is caused by a virus and not by bacteria. Effective antimicrobial stewardship is already under pressure, and one thing is certain: the problem will continue to grow until we find a solution. In other words, we are dealing with an invisible problem of similar proportions to the COVID-19 pandemic.

The broken antibiotics market

The pipeline of new antibiotics is running dry, because the market for antibiotics is broken. The development costs for newly approved antibiotics cannot be covered through sales. Most of the major pharmaceutical companies have stopped developing new antibiotics, and many smaller enterprises have folded due to the lack of a sustainable economic model.

The main reason is that newly developed, effective antibiotics are being used as a ‘last resort’ in the hospital sector: they are sensibly kept locked away in the medical cabinet, only to be used if the cheap generics fail. Of course, this is damaging to the manufacturers’ incentive, as it undermines the possibility to make revenues from new antibiotics.

The solution requires political intervention to reconstruct the market and make the development and production of antibiotics profitable again. We need to change the way we value antibiotics to make-up for costly development.

What is the World Economic Forum doing about epidemics?

Epidemics are a huge threat to health and the economy: the vast spread of disease can literally destroy societies.

In 2017, at our Annual Meeting, the Coalition for Epidemic Preparedness Innovations (CEPI) was launched – bringing together experts from government, business, health, academia and civil society to accelerate the development of vaccines against emerging infectious diseases and to enable access to them during outbreaks.Davos 2019 – Press Conference: CEPI – Building a Global C…

Our world needs stronger, unified responses to major health threats. By creating alliances and coalitions like CEPI, which involve expertise, funding and other support, we are able to collectively address the most pressing global health challenges.

Is your organisation interested in working with the World Economic Forum to tackle global health issues? Find out more here.

COVID-19 accelerates the AMR challenge

Meanwhile, we need to buy ourselves time by preventing overuse of existing antibiotics to avoid further resistance developing over time. AMR stewardship is already under pressure from limited restrictions of usage around the world, and the COVID-19 pandemic has accelerated the problem. The prevalence of AMR will likely increase through the heavy use of antibiotics in COVID-19 patient treatment.

Studies reporting on patients hospitalized with COVID-19 show widespread use of antibiotics as part of the general clinical care package, and data suggests that patients receive antibiotics even when it is not clinically indicated. In fact, a review of studies identified that while 72% of patients received antibiotics, only 8% demonstrated bacterial infections. A Nature article published in May last year concludes that many COVID-19 patients are meaninglessly getting antibiotics.

An opportunity not to be missed

The COVID-19 pandemic has hugely impacted the public understanding of healthcare prevention. All over the world, people are improving their hand-washing techniques and using antiseptic measures to prevent infections. At the same time, vaccine development efforts have shown cross-national cooperation in the race for an effective vaccine.

As such, the COVID-19 pandemic has made it obvious that global health challenges need to be addressed through a concerted effort by the international community. We must use this realization to intensify the battle against antimicrobial resistance, and it is actually a much easier and cheaper fix than COVID-19.

We have an opportunity to prepare ourselves on a global scale and (unlike viruses) when it comes to resistant bacteria, there is nothing new under the sun. As previously mentioned, 2,000 people die every day due to antimicrobial-resistant infections. Even if we start doing everything we can today, this number will increase before it will drop. If we fail to act a catastrophe is looming, but by pulling together and learning from the COVID-19 pandemic responses, we can mitigate the effects.

Recent developments in AMR

1. Introduction in the US of the PASTEUR Act, which aims to kick-start the development of urgently needed new antibiotics by changing the way the US government pays for them.

2. Progress on Swedish and UK government models implementing new AMR payment structures targeted at rebooting the broken marketplace.

3. The EU is to address several AMR challenges, including the lack of investment in antimicrobials and inappropriate use of antibiotics, as appears from the recent Pharmaceutical Strategy for Europe adopted by the Commission in November 2020.

4. The AMR Action Fund has raised US$1 billion from major pharmaceutical companies and foundations to invest in biotech. The aim is to bring as many as four new antibiotics to patients by 2030.

The solution to the AMR crisis is better stewardship of the miracle drugs that we call antibiotics as well as the introduction of one or two novel products per year. The cost for all of this is in the single-digit billion dollars range per year, or the equivalent of introducing a single successful cancer drug. The value to society in preventing the next pandemic is all too obvious. I call on the leadership of attendees of the World Economic Forum to seize the moment and continue to collaborate on pandemic preparedness including AMR in the coming years.

the sting Milestones

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

During the coronavirus pandemic, we must fight for LGBTQ rights more than ever

Final preparations for DCX and IFRA Expo 2019, in association with The European Sting

How two colossal Assyrian icons were recreated using digital tech

Libya: EU efforts should focus on protecting migrants, MEPs say

Difficulties of vaccination against COVID-19

EU takes again positive action on migration crisis while Turkey asks for dear favors in exchange for cooperation

Project Manager – 2024

Social media and the lack of information for blood donation

Commission welcomes provisional agreement on the European Climate Law

The EU to bear the cost of eventual sanctions against Russia

Saudi woman seeking asylum in Thailand ‘now in a secure place’ says UNHCR

A 550 km-long mass of rotting seaweed is heading for Mexico’s pristine beaches

Lack of investment and ambition means Youth Guarantee not reaching potential

This is the life of a refugee: the constant destruction and construction of dreams every day

This is where people live the longest in the EU

Nicaragua ‘crisis’ still cause for concern amid murder, torture allegations: Bachelet

This is our chance to completely redefine the meaning of work

European Green Deal: Commission presents actions to boost organic production

Green Deal: measures to step up the fight against global deforestation

These are the countries where most adults still don’t have a smartphone

It’s just electronic cigarette, don’t worry?

Historian Niall Ferguson on what the pandemic means for the global economy, geopolitics – and parties

Coronavirus response: Commission welcomes agreement on crucial VAT relief for vaccines and testing kits

Portuguese Presidency outlines priorities to EP committees

Romanian Presidency priorities discussed in committees

EU is now giving Google new monopolies to the detriment of European citizens and Internet companies

Mexico: UN chief saddened by pipeline blast in which dozens were killed

The 28 EU leaders show contempt for the European Elections results

Thursday’s Daily Brief: ambulance attack in Libya, #GlobalGoals defenders, human rights in Cambodia, Swine Fever

Pay Transparency: Commission proposes measures to ensure equal pay for equal work

This is how drones and other ‘tradetech’ are transforming international trade

Make no mistake: the purpose of business is to serve society

These are the top countries for travel and tourism in 2019

Rare Disease Day: a new EU platform to support better diagnosis and treatment

Spanish and Polish voters are crying out for an imminent European change while US urge now Germany to change route

EU co-ordinating the urgent delivery of COVID-19 vaccines to Moldova

Why global collaboration is needed to protect against a new generation of cyber threats

Does upgrading our minds mean losing the spark of genius?

This Brooklyn farm company is training a new generation of urban farmers

Countries are piling on record amounts of debt amid COVID-19. Here’s what that means

A brief history of cryptography and why it matters

Yemen: €95 million in EU humanitarian aid for people threatened by conflict and famine

Parliament: No consent to EU budget until €11.2 billion unpaid bills are settled

Chinese tech investors are turning towards MENA. Here’s why

Can Obama attract Iran close to the US sphere of influence?

How our Europe will regain its strength: op-ed by Ursula von der Leyen, President of the European Commission

From underestimation to valorization: how mobile technology is transforming global health

The Khashoggi affair: A global complot staged behind closed doors

Safe spaces offer security and dignity for youth, and help make the world ‘better for all’: Guterres

Smart city experts should be looking to emerging markets. Here’s why

Brazil identifies a clear pathway for aligning its transfer pricing framework with the OECD standard

The public health system in Brazil as a promoter of sexual and reproductive health and rights: how does it help in the fight against HIV/AIDS?

Mountains matter, especially if you’re young, UN declares

At G20 Summit OECD’s Gurría says collective action vital to tackle global challenges

Top UN court orders Myanmar to protect Rohingya from genocide

How fungi could save the world

Why South Africa is on a path of economic renewal

Rule of Law: Commission launches infringement procedure to protect the independence of the Polish Supreme Court

Supply chains are on the cusp of a data-fed revolution. Here’s how businesses can succeed.

Global warming: our responsibility

More Stings?

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s